Filters
Other countries
Results: 1 to 11 of 11
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
HIV-1, resistance to, 609423 (CCL2 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Coronary artery disease, modifier of (CCL2 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 20 | 46 |
|
Hereditary pancreatitis (WES-based NGS panel of 16 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 16 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 696 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Fulgent Genetics United States | 3 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Results: 1 to 11 of 11
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.